Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic inflammatory disorder of the gastrointestinal tract. Genetic studies and mouse models have shown that genetic predispositions interact with microbial and environmental factors to disrupt the host-commensal relationship, leading to IBD. Genome-wide association studies (GWAS) have identified 99 non-overlapping genetic risk loci for IBD, with 28 shared between Crohn's disease and ulcerative colitis. These loci are involved in pathways such as barrier function, microbial defense, and immune regulation. Genetic variants can vary in frequency depending on ethnicity, and rare variants may have emerged due to historical selective pressures. GWAS have identified key molecular pathways involved in IBD, including autophagy, ER stress, and cytokine signaling. The intestinal epithelium maintains a functional balance with the luminal microbiota, and disruptions in this balance contribute to IBD pathophysiology. Epithelial cells perform barrier and signal-transduction functions, and defects in epithelial integrity, such as those seen in Crohn's disease, can lead to increased permeability and inflammation. Paneth cells, which secrete antimicrobial effectors, play a crucial role in maintaining gut homeostasis. Defects in Paneth cell biology may contribute to Crohn's disease. The intestinal barrier is supported by a pre-epithelial layer of mucus, trefoil peptides, IgA, and antimicrobial peptides. Defects in this layer are associated with IBD. The innate immune system, including dendritic cells, macrophages, and neutrophils, is crucial for maintaining gut homeostasis. Defective innate immune responses are associated with IBD. NOD2 and CARD9 are key genes involved in IBD pathogenesis, with NOD2 recognizing peptidoglycan and CARD9 integrating signals from innate immune receptors. Autophagy, regulated by genes such as ATG16L1 and IRGM, is involved in bacterial clearance and immune response. Redox equilibrium is also important in IBD, with ROS playing a role in antimicrobial activity and immune signaling. Adaptive immunity involves T regulatory cells (Treg) and T helper 17 (Th17) cells, which are critical for maintaining immune balance. Defects in Treg function or Th17 polarization can lead to chronic inflammation. The gut microbiota influences both innate and adaptive immune responses, with microbial ligands and metabolites modulating immune signaling. Microbial communities can be affected by host factors, diet, and environmental influences, and dysregulation of these interactions can contribute to IBD. The microbiota also plays a role in IgA production and mucosal immunity. Overall, understanding the complex interplay between host genetics, the microbiota, and environmental factors is essential for elucidating the mechanisms of IBD and developing effective therapies.Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic inflammatory disorder of the gastrointestinal tract. Genetic studies and mouse models have shown that genetic predispositions interact with microbial and environmental factors to disrupt the host-commensal relationship, leading to IBD. Genome-wide association studies (GWAS) have identified 99 non-overlapping genetic risk loci for IBD, with 28 shared between Crohn's disease and ulcerative colitis. These loci are involved in pathways such as barrier function, microbial defense, and immune regulation. Genetic variants can vary in frequency depending on ethnicity, and rare variants may have emerged due to historical selective pressures. GWAS have identified key molecular pathways involved in IBD, including autophagy, ER stress, and cytokine signaling. The intestinal epithelium maintains a functional balance with the luminal microbiota, and disruptions in this balance contribute to IBD pathophysiology. Epithelial cells perform barrier and signal-transduction functions, and defects in epithelial integrity, such as those seen in Crohn's disease, can lead to increased permeability and inflammation. Paneth cells, which secrete antimicrobial effectors, play a crucial role in maintaining gut homeostasis. Defects in Paneth cell biology may contribute to Crohn's disease. The intestinal barrier is supported by a pre-epithelial layer of mucus, trefoil peptides, IgA, and antimicrobial peptides. Defects in this layer are associated with IBD. The innate immune system, including dendritic cells, macrophages, and neutrophils, is crucial for maintaining gut homeostasis. Defective innate immune responses are associated with IBD. NOD2 and CARD9 are key genes involved in IBD pathogenesis, with NOD2 recognizing peptidoglycan and CARD9 integrating signals from innate immune receptors. Autophagy, regulated by genes such as ATG16L1 and IRGM, is involved in bacterial clearance and immune response. Redox equilibrium is also important in IBD, with ROS playing a role in antimicrobial activity and immune signaling. Adaptive immunity involves T regulatory cells (Treg) and T helper 17 (Th17) cells, which are critical for maintaining immune balance. Defects in Treg function or Th17 polarization can lead to chronic inflammation. The gut microbiota influences both innate and adaptive immune responses, with microbial ligands and metabolites modulating immune signaling. Microbial communities can be affected by host factors, diet, and environmental influences, and dysregulation of these interactions can contribute to IBD. The microbiota also plays a role in IgA production and mucosal immunity. Overall, understanding the complex interplay between host genetics, the microbiota, and environmental factors is essential for elucidating the mechanisms of IBD and developing effective therapies.